По моему мнению это не шлак, но до 2023 года ничего хорошего не будет

Сам купил и забыл. - 30% никак не беспокоит)

@jollyrodger ты молодец, а я на плечи взял

CAMBRIDGE, Mass., May 26, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that management will participate at two upcoming conferences in June using a virtual platform. Ian Somaiya, Chief Financial Officer of TCR2 Therapeutics, will present an update on Company progress at the Jefferies Virtual Healthcare Conference on June 2, 2021 at 2:30pm ET Management will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021 at 9:40am ET A live webcast of each presentation will be available on the Investors page of the Company’s website at www.investors.tcr2.com. An archived replay will be available for at least 30 days following the presentation.

Жди 25